These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1350198)

  • 1. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
    Shi D; He G; Cao S; Pan W; Zhang HZ; Yu D; Hung MC
    Mol Carcinog; 1992; 5(3):213-8. PubMed ID: 1350198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
    Akita K; Inagaki H; Sato S; Niimi T; Maeda H; Ninomiya S; Achiwa H; Kawaguchi H; Yamakawa Y; Fujii Y; Shimizu S; Eimoto T; Ueda R
    Jpn J Cancer Res; 2002 Sep; 93(9):1007-11. PubMed ID: 12359054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer.
    Feng XL; Li L; Gao YN; Zhang JJ; Xiao T; Ying JM; Gao JD; Sun YT; Cheng SJ
    Med Oncol; 2011 Mar; 28(1):336-41. PubMed ID: 20237870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
    Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
    Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
    Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
    Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
    Cantero R; Torres AJ; Maestro ML; Hernando F; Sanz MT; Del Barco V; Gómez A; Fernández C; Balibrea JL
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1119-25. PubMed ID: 10838527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer.
    Cantero R; Torres AJ; Maestro M; Fernández C; Hernando F; del Barco V; Sanz T; Balibrea JL
    World J Surg; 1999 Dec; 23(12):1294-9; discussion 1299-300. PubMed ID: 10552124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
    Natali PG; Nicotra MR; Bigotti A; Venturo I; Slamon DJ; Fendly BM; Ullrich A
    Int J Cancer; 1990 Mar; 45(3):457-61. PubMed ID: 1968437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
    Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
    J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
    Liu C; Tsao MS
    Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
    Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
    Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and c-erbB-2 expression in non-small-cell lung carcinoma (c-erbB-2 in non-small cell lung carcinoma).
    Bakir K; Uçak R; Tunçözgür B; Elbeyli L
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):55-8. PubMed ID: 11847606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.